Close
CDMO Safety Testing 2026
Novotech

iNova Pharmaceuticals throws open its doors to new product innovation with inaugural crowdsourcing project, iPitch

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Holista Launches Collagen Production JV With SCC in Collie

Holista Colltech Limited has entered into a binding joint...

AddParts Secures Funding for Pharma Manufacturing Resilience

AddParts, a UK-based technology company focused on improving operational...

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...
- Advertisement -

iNova Pharmaceuticals is inviting Consumer Health product developers worldwide to submit product innovations to iPitch โ€“ iNovaโ€™s collaborative new crowdsourcing project. Starting with four carefully curated product-based challenges, iPitch aims to draw out fresh ideas and prospective business partnerships. The first four public challenges will open on 23 September and close on 4 November 2019. The challenges will broadly cover:

1. Sore Throat Challenge
2. Vaporising Delivery System Challenge
3. Wound and Scar Challenge; and
4. A Wild Card challenge!

iPitch is open to anyone with a great idea for a product or device that has the potential for commercialisation according to the criteria set out for each challenge. iNovaโ€™s Executive Director and Head of Innovation, Filomena Maiese, believes iPitch represents a fantastic opportunity for innovators and iNova alike: โ€œWe know there are great Consumer Health product innovations out there that havenโ€™t yet been commercialised, and product developers who may not have the expertise or resources to bring their innovations to market. We are looking for efficacious, evidence-based products with innovative formulations and novel formatsโ€, Ms Maiese said. โ€œWe want to partner with innovators to deliver next-generation solutions to delight our consumers.โ€

Chief Executive Officer, Dan Spira, believes iNova offers an attractive platform for prospective business partners: โ€œiNova has a diverse stable of market-leading products, a trusted reputation among consumers and healthcare professionals, a unique multi-national footprint, a well-established operating platform and broad distribution network across 20 countries in Asia, Africa and ANZ. We have a strong track record of acquiring, launching and building Consumer Health productsโ€, said Mr Spira. โ€œThose factors make us a partner of choice for product owners and licensors globally.โ€ Written submissions will initially be assessed by an internal panel of judges. Select submissions for each challenge will then be short-listed for the iPitch Slam, where applicants will have the opportunity deliver their pitch in person. Further details on the initial four iPitch challenges can be found at www.inovapharma.com/innovation

About iNova Pharmaceuticals
iNova Pharmaceuticals is a multinational pharmaceutical and consumer health care company that markets and sells a wide range of market-leading products, primarily in the areas of weight management, cough & cold, throat, skin care and natural health. iNova Pharmaceuticals operates in over 20 countries across Asia-Pacific and Africa. iNova Pharmaceuticalsโ€™ vision is to provide trusted brands that improve peopleโ€™s health and well-being every day. More information about iNova Pharmaceuticals can be found at www.inovapharma.com.

 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Holista Launches Collagen Production JV With SCC in Collie

Holista Colltech Limited has entered into a binding joint...

AddParts Secures Funding for Pharma Manufacturing Resilience

AddParts, a UK-based technology company focused on improving operational...

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...

Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal

Teva Pharmaceuticals has entered into a definitive agreement to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป